Individualized compounding enables precise dose adjustments, alternative dosage forms, and allergen/excipient avoidance for ...
Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively from one country, ...
Cell and gene therapies (CGT) continue to advance in the pharmaceutical industry. Despite continued investment in R&D, the ...
Documented AI productivity gains include 28% faster target identification, 22% faster biomarker identification, and 20% ...
In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected ...
Adjusted EPS was $7.23, materially ahead of expectations, and 2026 adjusted EPS guidance was raised to >$18.25, aided by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results